NOVACYT S.A. (NCYT) — Audited financial results for the year ended 31 December 2023

Investor webinar replay

Replay transcript excerpt

Good morning, and welcome to the NOVACYT investor presentation. Throughout this recorded presentation, investors will be in listen only mode. Questions are encouraged and can be submitted at any time by the q and a tab situated in the right corner of your screen. Just simply type in your questions and press send. Company may not be in a position to answer every question received in the meeting itself, but the company can review all the questions submitted today and publish responses where it is appropriate to do so. Before we begin, I'd like to submit the following poll. And for the benefit of those joining us from France, I'd now like to hand you over to the management team from NOVACYT. Good morning. Good morning, everyone, and thank you for taking some time to join us this morning. Just by way of introduction, I'm delighted to be sat here today, you know, having newly been appointed as the CEO of NOVACYT on the May 1. For those who who who don't know me or or or worked with me before, I've spent the last six years being the CEO of Georgine Health, you know, driving the acquisition strategy and the growth strategy of that business. And prior to that, I was the CEO of an organization called the BBI Group. So I've been in diagnostic industry for about twenty five years, and I'm I'm really pleased and excited to be here today as your CEO. I'd just like to hand over to Steve to do a quick quick introduction as well, Steve. Thanks, Lynn. Good morning, everyone. So I'm the CFO. I was appointed to that role in the start of this year. Prior to that, excuse me, prior to that, I was a group finance director for around four years, and I've been at NOVACYT now for around seven years. Prior to that, I spent around ten years working at Hewlett Packard in various different roles....